+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Typing Intermediates Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6119034
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Blood Typing Intermediates Market is projected to reach USD 276.46 Million in 2026. It is expected to continue growing at a CAGR of 11.32%, reaching USD 520.28 Million by 2032.

Blood Typing Intermediates: Executive Overview

Blood typing intermediates are the reagents, reference materials, controls, and related inputs used across blood-group antigen testing, compatibility assessment, transfusion workflows, and diagnostic quality systems. Demand is shaped by transfusion safety requirements, laboratory accreditation, hospital capacity, blood-bank modernization, and the need for reliable performance across manual and automated testing environments. The market is operationally sensitive: consistency, traceability, cold-chain integrity, regulatory compliance, and lot-to-lot comparability are central purchasing considerations.

How Regulation and Laboratory Modernization Are Reshaping the Landscape

The landscape is being transformed by stronger emphasis on patient identification, standardized immunohematology procedures, validated quality controls, and documented reagent traceability. Laboratories are also moving toward higher-throughput platforms, workflow integration, barcode-based identification, and more consistent digital recordkeeping. These shifts raise the importance of interoperability, technical support, training, and dependable supply continuity alongside analytical performance. Procurement decisions increasingly involve the full operating workflow rather than an individual intermediate in isolation.

Artificial Intelligence Is Improving Interpretation and Quality Management

Artificial intelligence can support blood typing workflows by helping identify discrepant patterns, prioritize exceptions, detect unusual quality-control results, and assist with image or signal interpretation on compatible analytical systems. Its practical value depends on representative validation data, transparent performance monitoring, cybersecurity, human oversight, and clear escalation procedures. AI is therefore most useful as a decision-support layer that complements qualified transfusion professionals, laboratory controls, and established confirmation testing rather than replacing them.

Regional Insights: Diverse Regulatory and Infrastructure Priorities

North America is characterized by mature transfusion infrastructure, rigorous laboratory oversight, and demand for automation, interoperability, and documented quality systems. Europe places strong emphasis on harmonized safety practices, traceability, and compliance across interconnected national systems. Asia-Pacific combines advanced laboratory environments with rapidly expanding healthcare capacity, creating varied requirements for automation, training, localization, and supply resilience. Latin America is shaped by uneven infrastructure, public-health priorities, and the need for dependable distribution and technical support. The Middle East continues to prioritize centralized healthcare modernization, specialized laboratory capability, and reliable procurement. Africa presents a broad mix of national systems, with access, workforce development, equipment maintenance, and logistics remaining important implementation considerations.

Group Insights: Economic and Security Blocs Shape Procurement Context

ASEAN markets reflect differing levels of laboratory maturity and regulatory alignment, making regional adaptability and local support important. BRICS members span large and diverse healthcare systems, where domestic capability, affordability, and resilient supply chains can influence adoption. The European Union emphasizes cross-border consistency, quality documentation, and regulatory coordination. G7 environments generally support advanced automation, high documentation standards, and integration with established laboratory information systems. GCC markets often focus on centralized procurement, specialist healthcare investment, and dependable technical service. NATO members represent varied national systems, but continuity planning, logistics resilience, and critical healthcare preparedness are relevant shared considerations.

Country Insights: Local Systems Determine Implementation Priorities

Australia and Canada emphasize quality assurance, geographically resilient distribution, and integration across dispersed healthcare networks. Brazil, Mexico, India, China, and Russia combine substantial healthcare needs with varied regional infrastructure, creating demand for scalable workflows, local support, and dependable availability. France, Germany, Italy, Spain, and the United Kingdom operate within mature regulatory and transfusion environments where traceability, validation, interoperability, and laboratory efficiency are prominent priorities. Japan and South Korea place strong emphasis on precision, automation, process standardization, and advanced hospital infrastructure. Across the United States, purchasing decisions commonly reflect accreditation, workflow efficiency, supply continuity, and compatibility with established blood-bank systems.

Actions for Leaders: Build Trust Through Quality, Resilience, and Workflow Fit

Industry leaders should prioritize robust lot-release testing, reference-material traceability, transparent documentation, and proactive technical support. Portfolio planning should address manual and automated laboratory settings, while interoperability should be treated as a product requirement rather than an optional feature. Supply strategies should include qualified sources, contingency inventory, cold-chain controls, and regionally appropriate distribution. Organizations should validate AI-enabled functions through controlled studies, monitor performance after deployment, and preserve expert review for discrepant or high-risk results. Finally, partnerships with laboratories and training institutions can improve implementation quality and strengthen long-term user confidence.

Research Methodology: Evidence-Based Assessment of Operating Conditions

This executive summary uses a structured assessment of the blood typing intermediates value chain, focusing on clinical use cases, laboratory workflows, regulatory expectations, technology adoption, procurement requirements, and regional implementation conditions. Insights are synthesized by comparing the needs of transfusion services, hospitals, reference laboratories, diagnostic networks, and quality systems across the specified regions, groups, and countries. The approach emphasizes verifiable operational drivers and avoids unsupported market estimates, forecasts, market shares, and company-specific claims. Interpretation should be refreshed as regulations, testing platforms, supply conditions, and clinical practices evolve.

Conclusion: Reliable Intermediates Support Safer, More Connected Testing

Blood typing intermediates remain foundational to dependable immunohematology and transfusion operations. The strongest opportunities for operational improvement lie in combining analytical consistency with traceability, automation readiness, workforce capability, digital integration, and resilient supply planning. Regional and country conditions differ substantially, but the common priorities are clear: accurate testing, controlled processes, qualified oversight, and continuous quality improvement. Leaders that align products and services with these requirements will be better positioned to support safe, efficient, and adaptable blood-bank workflows.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Typing Intermediates Market, by Product Type
7.1. Introduction
7.2. Product Type
7.2.1. Enzymes
7.2.1.1. Glycosidase Enzymes
7.2.1.2. Proteolytic Enzymes
7.2.2. Monoclonal Antibodies
7.2.2.1. Iga
7.2.2.2. Igg
7.2.2.3. Igm
7.2.3. Polyclonal Antibodies
7.2.3.1. Goat Derived
7.2.3.2. Rabbit Derived
7.2.3.3. Sheep Derived
7.2.4. Reagents
7.2.4.1. Dry Reagents
7.2.4.2. Solution Reagents
7.2.4.3. Suspension Reagents
8. Blood Typing Intermediates Market, by Application
8.1. Introduction
8.2. Application
8.2.1. Abo Typing
8.2.1.1. Forward Typing
8.2.1.2. Reverse Typing
8.2.2. Antibody Screening And Identification
8.2.2.1. Auto Control
8.2.2.2. Enzyme Treated
8.2.2.3. Panel Testing
8.2.3. Cross Matching
8.2.3.1. Electronic Cross Matching
8.2.3.2. Serological Cross Matching
8.2.4. Rh Typing
8.2.4.1. Pcr Based Rh Typing
8.2.4.2. Serological Rh Typing
9. Blood Typing Intermediates Market, by End User
9.1. Introduction
9.2. Blood Banks
9.2.1. Private Blood Banks
9.2.2. Public Blood Banks
9.3. Diagnostic Laboratories
9.3.1. Hospital Associated Labs
9.3.2. Independent Labs
9.4. Hospitals
9.4.1. Large Hospitals
9.4.2. Small And Medium Hospitals
9.5. Research Institutes
10. Blood Typing Intermediates Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributors
10.4. Online Channels
10.4.1. Third Party E Commerce
10.4.2. Vendor Website
11. Blood Typing Intermediates Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Blood Typing Intermediates Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Blood Typing Intermediates Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Agena Bioscience, Inc.
15.3. AXO Science SAS
15.4. BAG Diagnostics GmbH
15.5. Bio-Rad Laboratories, Inc.
15.6. Danaher Corporation
15.7. DiaMed GmbH
15.8. Grifols, S.A.
15.9. Helena Biosciences Europe Ltd.
15.10. Immucor, Inc.
15.11. Lorne Laboratories Limited
15.12. Merck KGaA
15.13. Novacyt Group
15.14. Ortho Clinical Diagnostics, Inc.
15.15. QuidelOrtho Corporation
15.16. Quotient Limited
15.17. Rapid Labs Ltd
15.18. Siemens Healthineers AG
15.19. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Blood Typing Intermediates Market, Years Considered for the Study
FIGURE 2. Global Blood Typing Intermediates Market, Research Design
FIGURE 3. Global Blood Typing Intermediates Market, Research Framework
FIGURE 4. Global Blood Typing Intermediates Market, Data Triangulation
FIGURE 5. Global Blood Typing Intermediates Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Blood Typing Intermediates Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Blood Typing Intermediates Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Blood Typing Intermediates Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Blood Typing Intermediates Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Blood Typing Intermediates Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Blood Typing Intermediates Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Blood Typing Intermediates Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Blood Typing Intermediates Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Blood Typing Intermediates Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Blood Typing Intermediates Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Blood Typing Intermediates Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Blood Typing Intermediates Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Blood Typing Intermediates Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Blood Typing Intermediates Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Blood Typing Intermediates Market Segmentation & Coverage
TABLE 2. Global Blood Typing Intermediates Market Size, 2017-2032 (USD Million)
TABLE 3. Global Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Product Type Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Product Type Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Product Type Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Glycosidase Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Glycosidase Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Glycosidase Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Proteolytic Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Proteolytic Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Proteolytic Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Iga Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Iga Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Iga Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Igg Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Igg Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Igg Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Igm Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Igm Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Igm Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Polyclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Polyclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Polyclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Goat Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Goat Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Goat Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Rabbit Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Rabbit Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Rabbit Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Sheep Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Sheep Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Sheep Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Dry Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Dry Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Dry Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Solution Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Solution Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Solution Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Suspension Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Suspension Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Suspension Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 53. Global Application Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Application Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Application Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Abo Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Abo Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Abo Typing Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Forward Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Forward Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Forward Typing Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Reverse Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Reverse Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Reverse Typing Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Antibody Screening And Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Antibody Screening And Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Antibody Screening And Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Auto Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Auto Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Auto Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Enzyme Treated Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Enzyme Treated Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Enzyme Treated Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Panel Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Panel Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Panel Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Cross Matching Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Cross Matching Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Cross Matching Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Electronic Cross Matching Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Electronic Cross Matching Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Electronic Cross Matching Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Serological Cross Matching Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Serological Cross Matching Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Serological Cross Matching Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Rh Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Rh Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Rh Typing Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Pcr Based Rh Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Pcr Based Rh Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Pcr Based Rh Typing Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Serological Rh Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Serological Rh Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Serological Rh Typing Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Global Blood Banks Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Blood Banks Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Blood Banks Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Private Blood Banks Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Private Blood Banks Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Private Blood Banks Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Public Blood Banks Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Public Blood Banks Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Public Blood Banks Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Hospital Associated Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Hospital Associated Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Hospital Associated Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Independent Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Independent Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Independent Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Large Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Large Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Large Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Small And Medium Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Small And Medium Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Small And Medium Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Online Channels Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Online Channels Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Online Channels Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Third Party E Commerce Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Third Party E Commerce Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Third Party E Commerce Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Vendor Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Vendor Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Vendor Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Blood Typing Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Blood Typing Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 162. North America Blood Typing Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. North America Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. North America Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. North America Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 166. North America Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 167. North America Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 168. North America Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 169. North America Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. North America Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. North America Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 172. North America Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 173. North America Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 174. North America Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 175. North America Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. North America Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 177. North America Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 178. North America Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 179. North America Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. North America Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 181. Latin America Blood Typing Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Latin America Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Latin America Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Latin America Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 185. Latin America Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 186. Latin America Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 187. Latin America Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 188. Latin America Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Latin America Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Latin America Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 191. Latin America Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 192. Latin America Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 193. Latin America Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 194. Latin America Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Latin America Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 196. Latin America Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 197. Latin America Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 198. Latin America Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Latin America Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 200. Europe Blood Typing Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Europe Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Europe Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Europe Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 204. Europe Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 205. Europe Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 206. Europe Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 207. Europe Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Europe Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Europe Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 210. Europe Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 211. Europe Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 212. Europe Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 213. Europe Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Europe Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 215. Europe Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 216. Europe Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 217. Europe Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Europe Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 219. Middle East Blood Typing Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Middle East Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Middle East Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Middle East Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 223. Middle East Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 224. Middle East Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 225. Middle East Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 226. Middle East Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Middle East Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Middle East Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 229. Middle East Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 230. Middle East Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 231. Middle East Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 232. Middle East Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Middle East Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 234. Middle East Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 235. Middle East Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 236. Middle East Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Middle East Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 238. Africa Blood Typing Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 239. Africa Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. Africa Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. Africa Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 242. Africa Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 243. Africa Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 244. Africa Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 245. Africa Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Africa Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. Africa Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 248. Africa Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 249. Africa Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 250. Africa Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 251. Africa Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Africa Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 253. Africa Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 254. Africa Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 255. Africa Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Africa Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 257. Global Blood Typing Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. ASEAN Blood Typing Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. ASEAN Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. ASEAN Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. ASEAN Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 262. ASEAN Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 263. ASEAN Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 264. ASEAN Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 265. ASEAN Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. ASEAN Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. ASEAN Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 268. ASEAN Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 269. ASEAN Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 270. ASEAN Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 271. ASEAN Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. ASEAN Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 273. ASEAN Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 274. ASEAN Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 275. ASEAN Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. ASEAN Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 277. GCC Blood Typing Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. GCC Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. GCC Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 280. GCC Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 281. GCC Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 282. GCC Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 283. GCC Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 284. GCC Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. GCC Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. GCC Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 287. GCC Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 288. GCC Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 289. GCC Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 290. GCC Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. GCC Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 292. GCC Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 293. GCC Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 294. GCC Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. GCC Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 296. European Union Blood Typing Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. European Union Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. European Union Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. European Union Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 300. European Union Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 301. European Union Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 302. European Union Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 303. European Union Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. European Union Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. European Union Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 306. European Union Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 307. European Union Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 308. European Union Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 309. European Union Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. European Union Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 311. European Union Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 312. European Union Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 313. European Union Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 314. European Union Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 315. BRICS Blood Typing Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 316. BRICS Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 317. BRICS Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 318. BRICS Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 319. BRICS Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 320. BRICS Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 321. BRICS Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 322. BRICS Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 323. BRICS Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. BRICS Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 325. BRICS Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 326. BRICS Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 327. BRICS Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 328. BRICS Blood Typing Intermediates Market Size, by End User, 2017-2032 (USD Million)
TABLE 329. BRICS Blood Typing Intermediates Market Size, by Blood Banks, 2017-2032 (USD Million)
TABLE 330. BRICS Blood Typing Intermediates Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 331. BRICS Blood Typing Intermediates Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 332. BRICS Blood Typing Intermediates Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 333. BRICS Blood Typing Intermediates Market Size, by Online Channels, 2017-2032 (USD Million)
TABLE 334. G7 Blood Typing Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 335. G7 Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 336. G7 Blood Typing Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 337. G7 Blood Typing Intermediates Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 338. G7 Blood Typing Intermediates Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 339. G7 Blood Typing Intermediates Market Size, by Polyclonal Antibodies, 2017-2032 (USD Million)
TABLE 340. G7 Blood Typing Intermediates Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 341. G7 Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 342. G7 Blood Typing Intermediates Market Size, by Application, 2017-2032 (USD Million)
TABLE 343. G7 Blood Typing Intermediates Market Size, by Abo Typing, 2017-2032 (USD Million)
TABLE 344. G7 Blood Typing Intermediates Market Size, by Antibody Screening And Identification, 2017-2032 (USD Million)
TABLE 345. G7 Blood Typing Intermediates Market Size, by Cross Matching, 2017-2032 (USD Million)
TABLE 346. G7 Blood Typing Intermediates Market Size, by Rh Typing, 2017-2032 (USD Million)
TABLE 347. G7 Blood Typing Int

Companies Mentioned

  • Abbott Laboratories
  • Agena Bioscience, Inc.
  • AXO Science SAS
  • BAG Diagnostics GmbH
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaMed GmbH
  • Grifols, S.A.
  • Helena Biosciences Europe Ltd.
  • Immucor, Inc.
  • Lorne Laboratories Limited
  • Merck KGaA
  • Novacyt Group
  • Ortho Clinical Diagnostics, Inc.
  • QuidelOrtho Corporation
  • Quotient Limited
  • Rapid Labs Ltd
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.